IDiyas

For the Inventor, By the Inventor

Boulder, CO, United States of America

Biodesix, Inc.


USPTO Granted Patents = 50



Trademarks = 23

Forward Citations = 309

Loading Chart...
Loading Chart...

33 inventors (with patents filed for the assignee):

goldMedal Heinrich Röder (40 out of 40 patents)

silverMedal Joanna Röder (24 out of 24 patents)

bronzeMedal Julia Grigorieva (23 out of 23 patents)

4.  Maxim Tsypin (20 out of 20 patents)

5.  Carlos Oliveira (11 out of 11 patents)

6.  Paul Edward Kearney (7 out of 22 patents)

7.  Clive Hayward (7 out of 13 patents)

8.  Xiao-Jun Li (7 out of 14 patents)

9.  Arni Steingrimsson (6 out of 6 patents)

10.  Kenneth Charles Fang (5 out of 11 patents)

11.  Krista Meyer (5 out of 5 patents)

12.  Senait Asmellash (5 out of 5 patents)

13.  Kevin Sayers (3 out of 3 patents)

14.  Caroline Maher (3 out of 3 patents)

15.  Gary A Pestano (3 out of 17 patents)


Core Competencies:
Lung Cancer Diagnosis
Predictive Testing
Mass Spectrometry
Immunotherapy Benefit
Cancer Patient Classification
Biomarker Identification
EGFR Pathway Targeting
MALDI-TOF Technology
Blood Sample Analysis
Prognostic Testing
Antibody Drug Development
Clinical Diagnostics

50 patents:

1. 12247980 - Compositions, methods and kits for diagnosis of lung cancer (2025-03-11),
2. 12230398 - Predictive test for patient benefit from antibody drug blocking ligand activation of the T-cell programmed cell death 1 (PD-1) checkpoint protein and classifier development methods (2025-02-18),
3. 12094587 - Apparatus and method for identification of primary immune resistance in cancer patients (2024-09-17),
4. 11913957 - Compositions, methods and kits for diagnosis of lung cancer (2024-02-27),
5. 11894147 - Method for predicting risk of unfavorable outcomes, e.g., in COVID-19 hospitalization, from clinical characteristics and basic laboratory findings (2024-02-06),
6. 11710539 - Predictive test for melanoma patient benefit from interleukin-2 (IL2) therapy (2023-07-25),
7. 11621057 - Classifier generation methods and predictive test for ovarian cancer patient prognosis under platinum chemotherapy (2023-04-04),
8. 11594403 - Predictive test for prognosis of myelodysplastic syndrome patients using mass spectrometry of blood-based sample (2023-02-28),
9. 11542340 - Antibodies targeting pulmonary nodule specific biomarkers and uses thereof (2023-01-03),
10. 11476003 - Method for predicting risk of unfavorable outcomes, e.g., in COVID-19 hospitalization, from clinical characteristics and basic laboratory findings (2022-10-18),
11. 11467167 - SRM methods in Alzheimer's disease and neurological disease assays (2022-10-11),
12. 11193935 - Compositions, methods and kits for diagnosis of lung cancer (2021-12-07),
13. 11150238 - Method for identification of cancer patients with durable benefit from immunotherapy in overall poor prognosis subgroups (2021-10-19),
14. 10950348 - Predictive test for patient benefit from antibody drug blocking ligand activation of the T-cell programmed cell death 1 (PD-1) checkpoint protein and classifier development methods (2021-03-16),
15. 10870891 - Diagnostic test system for specific, sensitive and reproducible detection of circulating nucleic acids in whole blood (2020-12-22),
Biodesix is a molecular diagnostics company that provides personalized medicine solutions for lung cancer. They offer blood-based tests and genomic profiling to aid in the diagnosis, treatment, and monitoring of patients with lung cancer. With a focus on precision medicine, Biodesix aims to improve patient outcomes through targeted therapies and individualized treatment plans.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Dec 2 2025

...
50 Patents

#25 in Boulder, CO

#125 in Colorado

#6,762 in US

#13,566 in the World

...
Boulder, CO, United States of America

Biodesix, Inc.

Forward Citations = 309

33 inventors:

goldMedal Heinrich Röder (40 out of 40 patents)

silverMedal Joanna Röder (24 out of 24 patents)

bronzeMedal Julia Grigorieva (23 out of 23 patents)

4.  Maxim Tsypin (20 out of 20 patents)

5.  Carlos Oliveira (11 out of 11 patents)

Please report any incorrect information to support@idiyas.com
Loading…